(Updates with stock price movement in the headline and second paragraph)
Novo Nordisk A/S (NVO) and Hims & Hers Health (HIMS) partnered to enable US consumers to access NovoCare pharmacy directly through the Hims platform with a bundled offering of all dose strengths of Wegovy and a Hims membership for $599 a month, the companies said Tuesday.
Hims shares jumped 26% in recent Tuesday trading, and Novo Nordisk rose 3.6%.
Price: 64.89, Change: +2.27, Percent Change: +3.63
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。